SeaCrest Wealth Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,900	Closed	-$10K	–	1010
2019 Q1	$10K	Hold	1,900	–	–	﹤0.01%	1522
2018 Q4	$7K	Hold	1,900	–	–	﹤0.01%	1592
2018 Q3	$11K	Sell	1,900 -1,100	-37%	-$6.37K	﹤0.01%	1601
2018 Q2	$19K	Buy	+3,000	New	+$19K	﹤0.01%	1379